
New Formulations of GLP-1s Demonstrate Positive Results, Potentially ...
Jun 23, 2025 · Glucagon-like peptide-1 (GLP-1) receptor agonists are a well-established treatment option for obesity and type 2 diabetes. However, there is a growing need for additional options to …
Diabetes Breakthrough: New Treatment Eliminates Insulin
Oct 17, 2024 · Groundbreaking research presented at UEG Week 2024 introduces a promising new treatment approach for type 2 diabetes (T2D) that has the potential to greatly reduce or even …
What’s Next in Diabetes Care: Innovations and Insights
Apr 11, 2025 · From expanding treatment options to groundbreaking research, progress is happening. With each breakthrough, we move closer to better care, improved quality of life and—one day—a cure.
Emerging Breakthroughs In Diabetes Treatment: A New Era Of Hope
Mar 18, 2025 · From promising research to clinical-stage cell therapies and AI software updates, diabetes treatment and management is poised to change like never before.
New study hints at breakthrough treatment that may reverse type 2 diabetes
Millions of people have type 2 diabetes, and many carry out the daily routine of medication, blood sugar checks, and constant monitoring. News from a Las Vegas study has started to spark steady ...
7 Key Breakthroughs in Type 2 Diabetes Treatment for 2025
Jun 1, 2025 · The treatment of Type 2 diabetes is undergoing rapid transformation, with 2025 bringing promising new solutions for millions of patients. Breakthroughs in pharmaceuticals, digital health …
Breakthroughs in Type 2 Diabetes Treatment
Jul 7, 2025 · Discover the latest breakthroughs in Type 2 diabetes treatment, offering new hope and transforming care with innovative technologies and strategies.
Endocrinologist shares 5 new technologies that will revolutionise ...
Dec 21, 2025 · Managing diabetes is set to change dramatically by 2026. Endocrinologist reveals 5 cutting-edge technologies that will make care more precise and personalised.
What to Know About Orforglipron Oral GLP-1 | Eli Lilly and Company
Dec 18, 2025 · Discover frequently asked and common questions about Orforglipron, an oral GLP-1 medication that is in development for type 2 diabetes and obesity by Eli Lilly and Company.
Newer diabetes drugs: Surprising shared benefits and unique side ...
Aug 1, 2025 · Over the past decade or so there has been a daunting increase in the number and pharmacologic breadth of medications available to treat patients with diabetes mellitus. There are …